Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
OPERATING
Net loss	$ (13,895,737)	$ (14,407,809)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of property and equipment and intangibles	132,545	115,641
Amortization of deferred financing costs	187,739	210,249
Stock-based compensation expense	1,203,800	429,410
Accretion of debt discount	$ 425,086	172,374
Interest accrued on convertible notes		812,832
Stock-based compensation for services	$ 44,800	739,500
Stock-based merger transaction costs		3,321,537
Net change in operating working capital items	$ 874,566	434,472
Operating	$ (11,027,201)	(8,171,794)
INVESTING
Funds held in escrow		777,746
Acquisition of property and equipment	$ (77,765)	(112,328)
Acquisition of intangibles	(108,069)	(18,186)
Investing	$ (185,834)	647,232
FINANCING
Issuance of common shares from exercise of stock options		1
Proceeds from issuance of common shares for cash	$ 6,285,700	15,214,561
Proceeds from issuance of preferred shares for cash		1,035,135
Share issue costs	$ (62,556)	(796,247)
Proceeds from Convertible Debt		1,500,000
Financing costs on notes converted to shares		(134,088)
Proceeds from term loan facility		3,000,000
Financing costs of term loan facility		$ (471,345)
Repayment of long-term debt	$ (375,000)
Financing	5,848,144	$ 19,348,017
Effect of exchange rate changes on cash and cash equivalents	42,930	156,399
CHANGE IN CASH AND CASH EQUIVALENTS FOR THE YEAR	(5,321,961)	11,979,854
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	12,604,273	624,419
CASH AND CASH EQUIVALENTS, END OF YEAR	7,282,312	12,604,273
Supplementary information:
Interest paid	357,350	$ 145,000
Capital expenditures included in accrued liabilities	$ 4,090
Non-cash investing and financing:
Issuance of common stock in connection with conversion of notes payable		$ 20,765,988
Issuance of preferred stock in connection with conversion of notes payable		520,572
Debt discount on long-term debt		$ 1,027,000